Filing Flows › First Horizon (FHN) › Stock forecast & fair value
First Horizon (FHN) stock forecast and fair value
First Horizon (FHN) trades at $23.04. 21 analysts' median price target is $26.00 (+13%), from $25.00 to $31.00. Across 15 valuation methods the middle fair value is $18.36 (-20%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $16.72 | $18.36 | $21.06 | -20% |
| P/E vs peers, weighted | $18.19 | $20.35 | $21.64 | -12% |
| P/E vs peers, matched | $16.54 | $16.95 | $20.85 | -26% |
| Residual income | $17.30 | $17.94 | $18.61 | -22% |
| P/TBV vs ROTCE (bank peers) | $14.57 | $21.06 | $27.54 | -9% |
| Analysts' price targets | $25.00 | $27.13 | $31.00 | +18% |
| Shareholder yield (dividends + buybacks) | $31.46 | $35.67 | $41.18 | +55% |
| Justified P/TBV (Gordon growth) | $12.84 | $14.99 | $18.01 | -35% |
| Dividend discount (Gordon) | $9.89 | $11.54 | $13.86 | -50% |
| Stage-weighted value (financial (bank / insurer)) | $14.56 | $17.39 | $20.60 | -25% |
First Horizon's latest quarter
First Horizon, Q3 2026: revenue $407M (-54% year over year), operating margin -23.8%, net loss $79.0M, operating cash flow $623M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for FHN stock?
The median of 21 analysts' 12-month targets is $26.00, +13% from $23.04; the range is $25.00 to $31.00. The average rating is buy.
What is First Horizon's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $9.98 and $35.67, with a middle value of $18.36 against a price of $23.04. Each method's assumptions are on the page.
Does First Horizon usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is FHN stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.